|
|
|
AFRICA: 3-in-1 ARV to ease adherence
[This report does not necessarily reflect the views of the United Nations]
JOHANNESBURG, 6 July (PLUSNEWS) - A generic 3-in-1 anti-AIDS pill, recently approved by the US Food and Drug Administration (FDA), could greatly ease daily treatment regimens for patients in developing countries, a senior US official said on Wednesday.
Although it was not yet clear how cost-effective the new drug would be, HIV-positive people would take only one pill twice a day, which "should facilitate better therapies and better adherence", The New York Times quoted acting US Global AIDS Coordinator Mark Dybul as saying.
The fixed-dose combination tablet, manufactured by Aurobindo Pharma, an Indian generic drug company, will be available for purchase and distribution under the President's Emergency Plan for AIDS Relief (PEPFAR).
PEPFAR is a $15 billion initiative, launched by US President George W. Bush in 2003, for the prevention, treatment and care of HIV/AIDS in 12 African countries and the Caribbean.
[ENDS]
:: MORE NEWS BRIEFS ::
|
|
|
 |
|
|
|
|
|
|
|
| Links |
AIDS Media Center
|
The Global Fund to fight AIDS, Tuberculosis & Malaria
|
International Community of Women Living with HIV/AIDS
|
AEGIS
|
International HIV/AIDS Alliance
|
PlusNews does not take responsibility for info in links supplied.
|
|
|
|
|
|
[Back] [Home Page]
Click here to send any feedback,
comments or questions you have about PlusNews Website or if you prefer you can
send an Email to Webmaster
Copyright IRIN 2006
The material contained on www.PlusNews.org comes to you via IRIN, a UN humanitarian news and information service, but may not necessarily reflect
the views of the United Nations or its agencies.
All PlusNews material may be reposted or reprinted free-of-charge; refer to the IRIN copyright page for conditions of use. IRIN is a project of the UN
Office for the Coordination of Humanitarian Affairs.
|
